Acorda Therapeutics Inc (NASDAQ:ACOR)

23.40
Delayed Data
As of 10:36am ET
 +0.15 / +0.65%
Today’s Change
13.60
Today|||52-Week Range
29.60
+9.09%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues139.4M141.1M188.4M106.2M
 
 
 
 
 
Cost of Goods Sold23.7M24.4M44.6M18.0M
 
 
 
 
 
Depreciation And Amortization6.1M5.8M5.8M3.3M
 
 
 
 
 
 
Operating ExpensesGross Income109.6M110.9M138.0M84.8M
 
 
 
 
 
General Expenses92.9M74.0M78.2M78.2M
 
 
 
 
 
Research And Development45.6M33.3M35.2M30.6M
 
 
 
 
 
Total Operating Expenses122.8M104.1M128.6M99.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income16.7M36.9M59.8M6.7M
 
 
 
 
 
Extraordinary Credit--400.0K--0.00
 
 
Extraordinary Charge-14.0M-39.5M-281.4M-6.2M
 
 
 
 
 
Interest Expense On Debt5.5M4.2M4.9M5.5M
 
 
 
 
 
Other Expenses4.0K-18.0K3.5M-5.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.7M-6.3M-223.0M-4.7M
 
 
 
 
 
Income Taxes-5.5M-18.9M-51.9M-3.5M
 
 
 
 
 
Net Income-8.2M-25.2M-171.1M-8.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS45.9M46.0M46.2M46.5M
 
 
 
 
 
Shares To Calculate EPS Diluted45.9M46.0M46.2M46.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.55-$3.70-$0.18
 
 
 
 
 
EPS Diluted-$0.18-$0.55-$3.70-$0.18